HeartBeam (BEAT) Stock Forecast, Price Target & Predictions


OverviewOwnershipFinancialsChartTranscripts

BEAT Stock Forecast


HeartBeam stock forecast is as follows: an average price target of $10.00 (represents a 352.49% upside from BEAT’s last price of $2.21) and a rating consensus of 'Buy', based on 1 wall street analysts offering a 1-year stock forecast.

BEAT Price Target


The average price target for HeartBeam (BEAT) is $10.00 based on 1-year price targets from 1 Wall Street analysts in the past 3 months, with a price target range of $10.00 to $10.00. This represents a potential 352.49% upside from BEAT's last price of $2.21.

BEAT Analyst Ratings


Buy

According to 1 Wall Street analysts, HeartBeam's rating consensus is 'Buy'. The analyst rating breakdown for BEAT stock is 0 'Strong Buy' (0.00%), 1 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

HeartBeam Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 02, 2022-Industrial Alliance Securities$10.00$4.31132.17%352.49%
Row per page
Go to

The latest HeartBeam stock forecast, released on Dec 02, 2022 by Industrial Alliance Securities company, set a price target of $10.00, which represents a 132.17% increase from the stock price at the time of the forecast ($4.31), and a 352.49% increase from BEAT last price ($2.21).

HeartBeam Price Target by Period


1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$2.21$2.21$2.21
Upside/Downside-100.00%-100.00%-100.00%

In the current month, the average price target of HeartBeam stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to HeartBeam's last price of $2.21. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Dec 02, 2022Alliance Global Partners-BuyInitialise
Row per page
Go to

HeartBeam's last stock rating was published by Alliance Global Partners on Dec 02, 2022. The company Initialise its BEAT rating from "null" to "Buy".

HeartBeam Financial Forecast


HeartBeam Revenue Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 22Mar 20Mar 19Mar 18Mar 17Mar 16Mar 15Jun 14Sep 13Mar 12Mar 11Mar 10Mar 09
Revenue------------------$113.03M$103.98M$94.50M$55.88M$48.64M$43.44M$42.65M$31.87M$27.05M$34.00M$31.82M$35.72M
Avg Forecast$4.40M$3.40M$2.60M$2.00M$1.50M$1.10M$800.00K$500.00K$3.48M$2.67M$100.00K$50.00K$37.50K--$250.00K$40.00K$90.53M$108.01M$101.50M$71.18M$55.88M$24.32M$14.48M$21.32M$5.31M$29.50M$57.12M$40.65M$35.72M
High Forecast$4.40M$3.40M$2.60M$2.00M$1.50M$1.10M$800.00K$500.00K$3.48M$2.67M$100.00K$50.00K$37.50K--$250.00K$40.00K$108.63M$129.61M$121.80M$85.42M$67.06M$29.18M$17.37M$25.59M$6.37M$35.40M$68.54M$48.78M$42.86M
Low Forecast$4.40M$3.40M$2.60M$2.00M$1.50M$1.10M$800.00K$500.00K$3.48M$2.67M$100.00K$50.00K$37.50K--$250.00K$40.00K$72.42M$86.41M$81.20M$56.94M$44.70M$19.46M$11.58M$17.06M$4.25M$23.60M$45.69M$32.52M$28.58M
# Analysts11111111----111231411131813101819121617810
Surprise %------------------1.05%1.02%1.33%1.00%2.00%3.00%2.00%6.00%0.92%0.60%0.78%1.00%

HeartBeam's average Quarter revenue forecast for Sep 22 based on 14 analysts is $90.53M, with a low forecast of $72.42M, and a high forecast of $108.63M. BEAT's average Quarter revenue forecast represents a -19.91% decrease compared to the company's last Quarter revenue of $113.03M (Mar 20).

HeartBeam EBITDA Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 22Mar 20Mar 19Mar 18Mar 17Mar 16Mar 15Jun 14Sep 13Mar 12Mar 11Mar 10Mar 09
# Analysts11111111----111231411131813101819121617810
EBITDA----------------$-4.11M$-3.61M$24.93M$22.11M$17.56M$3.04M$7.38M$3.03M$-746.00K$800.00K$-1.51M$1.73M$-2.35M$1.29M
Avg Forecast-----------------$17.62M$23.77M$21.58M$11.81M$3.04M$8.11M$3.03M$-820.60K$2.88M$-1.65M$2.91M$-3.01M$857.33K
High Forecast-----------------$21.14M$28.52M$25.89M$14.17M$3.65M$9.74M$3.64M$-656.48K$3.46M$-1.32M$3.49M$-2.40M$1.03M
Low Forecast-----------------$14.09M$19.01M$17.26M$9.45M$2.44M$6.49M$2.42M$-984.72K$2.30M$-1.98M$2.33M$-3.61M$685.87K
Surprise %------------------0.20%1.05%1.03%1.49%1.00%0.91%1.00%0.91%0.28%0.92%0.60%0.78%1.50%

14 analysts predict BEAT's average Quarter EBITDA for Sep 22 to be $17.62M, with a high of $21.14M and a low of $14.09M. This is -29.33% lower than HeartBeam's previous annual EBITDA (Mar 20) of $24.93M.

HeartBeam Net Income Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 22Mar 20Mar 19Mar 18Mar 17Mar 16Mar 15Jun 14Sep 13Mar 12Mar 11Mar 10Mar 09
# Analysts11111111----111231411131813101819121617810
Net Income----------------$-3.88M$-3.52M$7.11M$11.69M$5.98M$196.00K$3.97M$-69.00K$-3.99M$-2.96M$-3.53M$-1.55M$-5.43M$-722.00K
Avg Forecast$-19.66M$-4.78M$-5.05M$-4.78M$-4.78M$-4.78M$-5.05M$-4.78M$-2.79M$-2.92M$-4.25M$-4.25M$-4.52M$-4.52M$-4.38M$-3.99M$-3.28M$5.12M$6.78M$11.40M$4.02M$196.00K$4.37M$-69.00K$-4.39M$-10.64M$-3.86M$-2.61M$-6.94M$-481.33K
High Forecast$-19.66M$-4.78M$-5.05M$-4.78M$-4.78M$-4.78M$-5.05M$-4.78M$-2.79M$-2.92M$-4.25M$-4.25M$-4.52M$-4.52M$-4.38M$-3.99M$-3.28M$6.15M$8.13M$13.68M$4.83M$235.20K$5.24M$-55.20K$-3.51M$-8.51M$-3.08M$-2.09M$-5.55M$-385.07K
Low Forecast$-19.66M$-4.78M$-5.05M$-4.78M$-4.78M$-4.78M$-5.05M$-4.78M$-2.79M$-2.92M$-4.25M$-4.25M$-4.52M$-4.78M$-4.38M$-3.99M$-3.28M$4.10M$5.42M$9.12M$3.22M$156.80K$3.49M$-82.80K$-5.26M$-12.77M$-4.63M$-3.13M$-8.33M$-577.60K
Surprise %----------------1.18%-0.69%1.05%1.02%1.49%1.00%0.91%1.00%0.91%0.28%0.92%0.60%0.78%1.50%

HeartBeam's average Quarter net income forecast for Sep 22 is $5.12M, with a range of $4.10M to $6.15M. BEAT's average Quarter net income forecast represents a -27.96% decrease compared to the company's last Quarter net income of $7.11M (Mar 20).

HeartBeam SG&A Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 22Mar 20Mar 19Mar 18Mar 17Mar 16Mar 15Jun 14Sep 13Mar 12Mar 11Mar 10Mar 09
# Analysts11111111----111231411131813101819121617810
SG&A----------------$2.10M$2.05M$45.33M$41.02M$39.29M$24.78M$20.05M$18.59M$18.43M$15.67M$14.82M$17.74M$17.67M$21.87M
Avg Forecast-----------------$33.87M$43.22M$40.02M$26.42M$24.78M$22.05M-$20.28M-$16.17M$29.80M$22.58M$14.58M
High Forecast-----------------$40.65M$51.86M$48.02M$31.70M$29.73M$26.46M-$24.33M-$19.41M$35.76M$27.10M$17.50M
Low Forecast-----------------$27.10M$34.58M$32.01M$21.13M$19.82M$17.64M-$16.22M-$12.94M$23.84M$18.07M$11.67M
Surprise %-----------------0.06%1.05%1.03%1.49%1.00%0.91%-0.91%-0.92%0.60%0.78%1.50%

HeartBeam's average Quarter SG&A projection for Mar 24 is -, based on 2 Wall Street analysts, with a range of - to -. The forecast indicates a -100.00% fall compared to BEAT last annual SG&A of $2.10M (Dec 23).

HeartBeam EPS Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 22Mar 20Mar 19Mar 18Mar 17Mar 16Mar 15Jun 14Sep 13Mar 12Mar 11Mar 10Mar 09
# Analysts11111111----111231411131813101819121617810
EPS----------------$-0.15$-0.43$0.21$0.35$0.18$0.01$0.15$-0.00$-0.15$-0.12$-0.14$-0.06$-0.23$-0.03
Avg Forecast$-0.74$-0.18$-0.19$-0.18$-0.18$-0.18$-0.19$-0.18$-0.10$-0.11$-0.16$-0.16$-0.17$-0.17$-0.17$-0.15$-0.12$-0.32$0.41$0.40$0.15$0.16$0.11$0.02$0.01$-0.07$-0.12$-0.25$-0.23$0.02
High Forecast$-0.74$-0.18$-0.19$-0.18$-0.18$-0.18$-0.19$-0.18$-0.10$-0.11$-0.16$-0.16$-0.17$-0.17$-0.17$-0.15$-0.12$-0.32$0.49$0.48$0.19$0.19$0.13$0.02$0.01$-0.06$-0.10$-0.20$-0.18$0.02
Low Forecast$-0.74$-0.18$-0.19$-0.18$-0.18$-0.18$-0.19$-0.18$-0.10$-0.11$-0.16$-0.16$-0.17$-0.18$-0.17$-0.15$-0.12$-0.32$0.33$0.32$0.12$0.13$0.09$0.02$0.01$-0.09$-0.14$-0.30$-0.28$0.02
Surprise %----------------1.22%1.34%0.51%0.87%1.20%0.04%1.36%-0.13%-15.00%1.71%1.17%0.24%1.00%-1.50%

According to 14 Wall Street analysts, HeartBeam's projected average Quarter EPS for Sep 22 is $-0.32, with a low estimate of $-0.32 and a high estimate of $-0.32. This represents a -252.38% decrease compared to BEAT previous annual EPS of $0.21 (Mar 20).

HeartBeam Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
UTRSMinerva Surgical$0.01$5.0049900.00%Buy
HLTHCue Health$0.04$8.0019900.00%Hold
HCTIHealthcare Triangle$0.33$2.00506.06%Buy
BEATHeartBeam$2.21$10.00352.49%Buy

BEAT Forecast FAQ


Yes, according to 1 Wall Street analysts, HeartBeam (BEAT) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 100.00% of BEAT's total ratings.

HeartBeam (BEAT) average price target is $10 with a range of $10 to $10, implying a 352.49% from its last price of $2.21. The data is based on 1 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

According to Wall Street analysts' prediction for BEAT stock, the company can go up by 352.49% (from the last price of $2.21 to the average price target of $10), up by 352.49% based on the highest stock price target, and up by 352.49% based on the lowest stock price target.

BEAT's average twelve months analyst stock price target of $10 supports the claim that HeartBeam can reach $3 in the near future.

HeartBeam's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $3.9M (high $3.9M, low $3.9M), average EBITDA is $0 (high $0, low $0), average net income is $-19.394M (high $-19.394M, low $-19.394M), average SG&A $0 (high $0, low $0), and average EPS is $-0.73 (high $-0.73, low $-0.73). BEAT's analysts financial forecasts for the fiscal year (Dec 2027) are as follows: average revenue is $12.4M (high $12.4M, low $12.4M), average EBITDA is $0 (high $0, low $0), average net income is $-34.271M (high $-34.271M, low $-34.271M), average SG&A $0 (high $0, low $0), and average EPS is $-1.29 (high $-1.29, low $-1.29).

In terms of the last quarterly report (Mar 2020), HeartBeam's revenue was $113.03M, beating the average analysts' forecast of $108.01M by 4.65%. The company's EBITDA was $24.92M, beating the average prediction of $23.77M by 4.88%. HeartBeam's net income was $7.11M, beating the average estimation of $6.78M by 4.88%. The company's SG&A was $45.33M, beating the average forecast of $43.22M by 4.88%. Lastly, the company's EPS was $0.21, missing the average prediction of $0.41 by -48.78%